ArticleNucleic acids research2025
Cell sorting based on single nucleotide variation enables characterization of mutation-dependent transcriptome and chromatin states.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Point mutations in oncogenes and tumor suppressor genes are common drivers of tumorigenesis. Moreover, single nucleotide variants (SNVs) also contribute to cancer by altering the noncoding regions of the genome. However, connecting SNVs to transcriptomic and epigenetic changes at the single-cell level remains challenging. To enable studies of rare populations of cells harboring specific point mutations, we developed STAR-FACS [Specific-To-Allele polymerase chain reaction (PCR) - fluorescence-activated cell sorting (FACS)]. This method allows for cell labeling based exclusively on genomic allele alteration, by in-cell DNA amplification. Labeled cells are then sorted and profiled with bulk or single cell transcriptomics. The labeling method is also compatible with downstream characterization of chromatin features with CUT&Tag (Cleavage Under Targets and Tagmentation). Our proof-of-principle study shows that STAR-FACS can be used to separate cells based on TERT promoter mutation status and is applicable to primary cell lines and dissociated solid tumor tissue. We demonstrate that glioblastoma cell lines derived from the same tumor but harboring distinct TERT promoter SNVs have different transcriptional programs. STAR-FACS provides a novel tool for studies linking subclonal noncoding SNVs with transcriptomic and epigenetic heterogeneity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.